СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Denou Emmanuel, Lolmède Karine, Garidou Lucile, Pomie Celine, Chabo Chantal, Lau Trevor C, Fullerton Morgan D, Nigro Giulia, Zakaroff-Girard Alexia, Luche Elodie, Garret Céline, Serino Matteo, Amar Jacques, Courtney Michael, Cavallari Joseph F, Henriksbo Brandyn D, Barra Nicole G, Foley Kevin P, McPhee Joseph B, Duggan Brittany M, O'Neill Hayley M, Lee Amanda J, Sansonetti Philippe, Ashkar Ali A, Khan Waliul I, Surette Michael G, Bouloumié Anne, Steinberg Gregory R, Burcelin Rémy, Schertzer Jonathan D
Аннотация
Pattern recognition receptors link metabolite and bacteria-derived inflammation to insulin resistance during obesity. We demonstrate that NOD2 detection of bacterial cell wall peptidoglycan (PGN) regulates metabolic inflammation and insulin sensitivity. An obesity-promoting high-fat diet (HFD) increased NOD2 in hepatocytes and adipocytes, and NOD2(-/-) mice have increased adipose tissue and liver inflammation and exacerbated insulin resistance during a HFD. This effect is independent of altered adiposity or NOD2 in hematopoietic-derived immune cells. Instead, increased metabolic inflammation and insulin resistance in NOD2(-/-) mice is associated with increased commensal bacterial translocation from the gut into adipose tissue and liver. An intact PGN-NOD2 sensing system regulated gut mucosal bacterial colonization and a metabolic tissue dysbiosis that is a potential trigger for increased metabolic inflammation and insulin resistance. Gut dysbiosis in HFD-fed NOD2(-/-) mice is an independent and transmissible factor that contributes to metabolic inflammation and insulin resistance when transferred to WT, germ-free mice. These findings warrant scrutiny of bacterial component detection, dysbiosis, and protective immune responses in the links between inflammatory gut and metabolic diseases, including diabetes.